Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Venema CM"'
Autor:
Boers J; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Venema CM; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., de Vries EFJ; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Boersma HH; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Rikhof B; Department of Internal Medicine, Medical Center Leeuwarden, Leeuwarden, the Netherlands., Dorbritz C; Medical Imaging Center, Department of Radiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Glaudemans AWJM; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Schröder CP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: c.p.schroder@umcg.nl.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Feb; Vol. 144, pp. 151-161. Date of Electronic Publication: 2020 Dec 18.
Autor:
Jager A; Erasmus MC Cancer Institute, Post Office Box 2040, 3000 CA, Rotterdam, Netherlands., de Vries EGE; University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, Netherlands., der Houven van Oordt CWM; Amsterdam UMC location VUMC, Cancer Center Amsterdam, De Boelelaan 1118, 1081 HV, Amsterdam, Netherlands., Neven P; UZ KU-Leuven, Herestraat 49, 3000, Leuven, Belgium., Venema CM; University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, Netherlands., Glaudemans AWJM; University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ, Groningen, Netherlands., Wang Y; Radius Health, Inc., 950 Winter Street, Waltham, MA, 02451, USA., Bagley RG; Radius Health, Inc., 950 Winter Street, Waltham, MA, 02451, USA., Conlan MG; Radius Health, Inc., 950 Winter Street, Waltham, MA, 02451, USA. mconlan@radiuspharm.com., Aftimos P; Clinical Trials Conduct Unit, Institut Jules Bordet - Université Libre de Bruxelles, Rue Héger-Bordet 1, 1000, Brussels, Belgium.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2020 Sep 11; Vol. 22 (1), pp. 97. Date of Electronic Publication: 2020 Sep 11.
Autor:
Mammatas LH; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VUmc University Medical Center Amsterdam, de Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands., Venema CM; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713, GZ, Groningen, The Netherlands., Schröder CP; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713, GZ, Groningen, The Netherlands., de Vet HCW; Department of Epidemiology and Biostatistics, Amsterdam Public Health Institute, Amsterdam UMC, VUmc University Medical Center Amsterdam, De Boelelaan 1105, 1081, HV, Groningen, The Netherlands., van Kruchten M; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713, GZ, Groningen, The Netherlands., Glaudemans AWJM; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713, GZ, Groningen, The Netherlands., Yaqub MM; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, VUmc University Medical Center Amsterdam, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands., Verheul HMW; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VUmc University Medical Center Amsterdam, de Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands., Boven E; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VUmc University Medical Center Amsterdam, de Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands., van der Vegt B; Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, DHanzeplein 1, 9713, GZ, Groningen, The Netherlands., de Vries EFJ; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713, GZ, Groningen, The Netherlands., de Vries EGE; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713, GZ, Groningen, The Netherlands., Hoekstra OS; Department of Radiology and Nuclear Medicine, Cancer Center Amsterdam, Amsterdam UMC, VUmc University Medical Center Amsterdam, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands., Hospers GAP; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9713, GZ, Groningen, The Netherlands., der Houven van Oordt CWM; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, VUmc University Medical Center Amsterdam, de Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands. c.menke@amsterdamumc.nl.
Publikováno v:
EJNMMI research [EJNMMI Res] 2020 Apr 19; Vol. 10 (1), pp. 40. Date of Electronic Publication: 2020 Apr 19.
Autor:
Boers J; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Venema CM; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., de Vries EFJ; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Glaudemans AWJM; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Kwee TC; Department of Radiology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Schuuring E; Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Martens JWM; Department of Medical Oncology, Erasmus MC, Erasmus University Medical Center, Rotterdam, the Netherlands., Elias SG; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Schröder CP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: c.p.schroder@umcg.nl.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2020 Feb; Vol. 126, pp. 11-20. Date of Electronic Publication: 2019 Dec 28.
Autor:
Venema CM; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., de Vries EFJ; Medical Imaging Center, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, the Netherlands., van der Veen SJ; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Dorrius MD; Medical Imaging Center, Department of Radiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., van Kruchten M; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Schröder CP; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Hospers GAP; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., Glaudemans AWJM; Medical Imaging Center, Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Hanzeplein 1, 9700 RB, Groningen, the Netherlands. a.w.j.m.glaudemans@umcg.nl.
Publikováno v:
EJNMMI research [EJNMMI Res] 2019 Aug 23; Vol. 9 (1), pp. 82. Date of Electronic Publication: 2019 Aug 23.
Autor:
Venema CM; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Bense RD; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Steenbruggen TG; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Nienhuis HH; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Qiu SQ; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; The Breast Center, Cancer Hospital of Shantou University Medical College, Shantou, China., van Kruchten M; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Brown M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States., Tamimi RM; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Hospers GAP; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Schröder CP; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Fehrmann RSN; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., de Vries EGE; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: e.g.e.de.vries@umcg.nl.
Publikováno v:
Pharmacology & therapeutics [Pharmacol Ther] 2019 Aug; Vol. 200, pp. 135-147. Date of Electronic Publication: 2019 May 08.
Autor:
Venema CM; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Mammatas LH; Department of Medical Oncology, VU University Medical Center, VUmc Cancer Center Amsterdam, Amsterdam, The Netherlands., Schröder CP; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., van Kruchten M; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Apollonio G; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Glaudemans AWJM; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Bongaerts AHH; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Hoekstra OS; Department of Radiology and Nuclear Medicine VU University Medical Center, Amsterdam, The Netherlands; and., Verheul HMW; Department of Radiology and Nuclear Medicine VU University Medical Center, Amsterdam, The Netherlands; and., Boven E; Department of Medical Oncology, VU University Medical Center, VUmc Cancer Center Amsterdam, Amsterdam, The Netherlands., van der Vegt B; Department of Pathology & Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., de Vries EFJ; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., de Vries EGE; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Boellaard R; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Menke van der Houven van Oordt CW; Department of Medical Oncology, VU University Medical Center, VUmc Cancer Center Amsterdam, Amsterdam, The Netherlands., Hospers GAP; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands g.a.p.hospers@umcg.nl.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2017 Dec; Vol. 58 (12), pp. 1906-1912. Date of Electronic Publication: 2017 Sep 14.
Autor:
Venema CM; From the Departments of *Medical Oncology, and †Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; and ‡Ghent University, Gent, Belgium., Apollonio G, Hospers GA, Schröder CP, Dierckx RA, de Vries EF, Glaudemans AW
Publikováno v:
Clinical nuclear medicine [Clin Nucl Med] 2016 Nov; Vol. 41 (11), pp. 844-851.
Autor:
van Es SC; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;, Venema CM; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;, Glaudemans AW; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;, Lub-de Hooge MN; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; and., Elias SG; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Boellaard R; Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;, Hospers GA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;, Schröder CP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;, de Vries EG; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; e.g.e.de.vries@umcg.nl.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2016 Feb; Vol. 57 Suppl 1, pp. 96S-104S.
Autor:
Balak DM; Department of Dermatology, Erasmus Medical Center, Rotterdam, The Netherlands., Fallah-Arani S, Venema CM, Neumann HA, Thio HB
Publikováno v:
The British journal of dermatology [Br J Dermatol] 2015 Mar; Vol. 172 (3), pp. 754-9. Date of Electronic Publication: 2015 Jan 18.